Document is current
Any future updates will be listed below
-
Authors
Gao, Han
Li, Sen
Lan, Zhengyi
Pan, Da https://orcid.org/0000-0001-8430-9467
Naidu, Gonna Somu
Peer, Dan https://orcid.org/0000-0001-8238-0673
Ye, Chenyi
Chen, Hangrong https://orcid.org/0000-0003-0827-1270
Ma, Ming https://orcid.org/0000-0002-1068-4528
Liu, Zehua https://orcid.org/0000-0002-4158-9072
Santos, Hélder A. https://orcid.org/0000-0001-7850-6309
-
Funding
Funding for this research was provided by:
Academy of Finland (331151)
- License Information
-
More Information
Article History
Received: 25 October 2023
Accepted: 19 June 2024
First Online: 26 June 2024
Competing interests
: D.P. receives licensing fees (to patents on which he was an inventor), has invested, has consulted, has been on the scientific advisory boards or boards of directors, given paid lectures or conducted research at Tel Aviv University sponsored by ART Biosciences, BioNTech SE, Earli, Kernal Biologics, Geneditor Biologics, Merck, NeoVac, Newphase, Roche, SirTLabs Corporation and Teva Pharmaceuticals. All other authors declare no competing interests.
